๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Wuhan
Clinical trial register · China

Clinical Trials in Wuhan, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology165 Tongji Hospital139 Huazhong University of Science and Technology45 Novartis Pharmaceuticals33 AbbVie31
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Wuhan

1343 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
An Open-label, Single-arm, Single-center Study to Evaluate the Diagnostic Efficacy of a Novel PET Probe, 68Ga-SFB6-ZN01, in Patients With Malignant Tumors
NCT07420036Neoplasms
Zhongnan Hospital
Phase EARLY_PHASE1
98
Wuhan
2026-03-10
Recruiting
A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo
NCT07431177Non-segmental Vitiligo
Novartis Pharmaceuticals
Phase 2
210
Guangzhou, Wuhan, Beijing, Shanghai
2026-03-09
Not yet open
A Study of GenSci134 in Children With Growth Hormone Deficiency (PGHD)
NCT07450001Pediatric Growth Hormone Deficiency
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1/2
128
Wuhan
2026-03-06
Not yet open
A Study (Phase 1b/2) of GenSci134 in Children With Idiopathic Short Stature (ISS)
NCT07450053Idiopathic Short Stature
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1/2
128
Wuhan
2026-03-06
Recruiting
Efficacy and Safety of Intrapulmonary Percussive Ventilation in Patients With Pulmonary Infection Receiving Invasive Mechanical Ventilation
NCT07453966Pneumonia
Zhongnan Hospital
Not applicable
110
Wuhan
2026-03-06
Recruiting
CAS for Stenosis With High-risk Features for CEA
NCT07370246Carotid Artery Stenosis, Carotid Artery Stenting
Beijing Tiantan Hospital
Not applicable
212
Beijing, Chongqing, Nanning, Guiyang, Shijiazhuang, Xingtai, Wuhan, Hohhot
2026-03-06
Recruiting
ART Trial: Transcatheter J-VALVE Versus Surgery for Aortic Regurgitation Therapy
NCT07453407Aortic Regurgitation, Aortic Valve Insufficiency, Aortic Insufficiency
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
1,250
Hefei, Beijing, Fuzhou, Guangzhou, Zhengzhou, Hong Kong, Wuhan, Changsha
2026-03-05
Recruiting
HMPL-A580 in Participants With Advanced or Metastatic Solid Tumor
NCT07396584Solid Tumors, Adult
Hutchmed
Phase 1/2
186
Changchun, Changsha, Jinan, Nanning, Shanghai, Wuhan, Xiamen, Zhengzhou
2026-03-04
Recruiting
A Study of Ziresovir (AK0529) in High-risk Adult With Respiratory Syncytial Virus (RSV) Infection.
NCT07658534Respiratory Syncytial Virus Infections
Shanghai Ark Biopharmaceutical Co., Ltd.
Phase 2/3
290
Beijing, Guangzhou, Cangzhou, Nanyang, Zhengzhou, Wuhan, Hangzhou, Ruiโ€™an
2026-03-03
Recruiting
A Clinical Study to Evaluate the Safety and Preliminary Efficacy of QI-019A in Patients With Relapsed/Refractory Multiple Myeloma.
NCT07429721Multiple Myeloma (MM)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase EARLY_PHASE1
24
Wuhan
2026-03-03
Recruiting
AI Assisted Screening for VHD Using Routine Chest CT Scans
NCT07449130Heart Valve Diseases
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
3,000
Wuhan, รœrรผmqi, Hangzhou
2026-03-02
Not yet open
EUS-guided CTCs + Multi-omics: Predicting Pancreatic Cancer Recurrence and Metastases
NCT07448376CTCs, Pancreatic Cancer, Liver Metastases, Relapse
Huazhong University of Science and Technology
Observational
20
Wuhan
2026-03-01
Recruiting
Fludarabine Plus Melphalan Versus Addition of Venetoclax to Fludarabine/Melphalan Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in AML/MDS Patients Aged > 50 Years: a Multicenter, Randomized, Phase 3 Trial
NCT07396480Venentoclax, Myeloid Malignancies, Conditioning, ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
First Affiliated Hospital of Zhejiang University
Phase 3
186
Fuzhou, Guangzhou, Zhengzhou, Wuhan, Changsha, Nanjing, Jinan, Hangzhou
2026-03-01
Recruiting
A Phase II Study of Sintilimab Combined With Ipilimumab N01, Cetuximab and Dabrafenib in Patients With Microsatellite-Stable, BRAF V600E-Mutated Metastatic Colorectal Cancer
NCT07506109BRAF V600E, Colorectal Cancer, Sintilimab, MSS (Microsatellite Stable)
Tianjin Medical University Cancer Institute and Hospital
Phase 2
49
Beijing, Wuhan, Chengdu, Tianjin
2026-03-01
Not yet open
Tongji NADs Cohort
NCT07333196Multiple Sclerosis, NMO Spectrum Disorder, Autoimmune Encephalitis, Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease
Tongji Hospital
Observational
1,550
Wuhan
2026-03-01
Not yet open
Lenvatinib Plus PD-1 Inhibitor for Advanced Solid Tumors With 11q13 Amplification
NCT07417501Solid Tumors
Tongji Hospital
Phase 2
60
Wuhan
2026-03-01
Recruiting
CD30 CAR-T in the Treatment of CD30 Positive Lymphoma
NCT07048353Lymphoma, B Cell Lymphoma, CD30+ Peripheral T-cell Lymphoma
Shandong Qilu Cell Therapy Engineering Technology Co., Ltd
Phase EARLY_PHASE1
15
Wuhan
2026-03-01
Recruiting
Impact of Pringle Maneuver on Postoperative Gallbladder Diseases After Hepatectomy
NCT07452848Gallbladder Diseases, Cholelithiasis
West China Hospital
Observational
2,000
Hefei, Chongqing, Guangzhou, Harbin, Wuhan, Nanjing, Tianjin
2026-03-01
By invitation
A Trial for Advanced Leiomyosarcoma With Human Organoid-guided Personalized Efficacy
NCT07405346Advanced Leiomyosarcoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Not applicable
50
Wuhan
2026-03-01
Recruiting
CHRONO-MOBILIZE: Chronotherapy of G-CSF for CD34+ Mobilization in Healthy Donors
NCT07423728Granulocyte Colony-Stimulating Factor (G-CSF) Mobilization
First Affiliated Hospital of Zhejiang University
Not applicable
160
Zhengzhou, Wuhan, Hangzhou
2026-03-01
Recruiting
PIC1 Injection Therapy for Relapsed/Refractory B-NHL
NCT07456371Non-Hodgkin Lymphoma
Chongqing Precision Biotech Co., Ltd
Phase 1
18
Wuhan
2026-03
Recruiting
Durvalumab as Consolidation for Patients LS-SCLC
NCT07055581Small Cell Lung Cancer Limited Stage
Qian Chu
Phase 2
100
Zhengzhou, Wuhan
2026-02-24
Not yet open
A Clinical Study Evaluating the Safety and Preliminary Efficacy of Universal Allogeneic CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C)in Patients With Refractory Primary Immune Thrombocytopenia
NCT07416032Immune Thrombocytopenia (ITP)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase EARLY_PHASE1
27
Wuhan
2026-02-20
Recruiting
A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)
NCT07363590Systemic Lupus Erythematosus, Rheumatoid Arthritis
Merck Sharp & Dohme LLC
Phase 1
21
Beijing, Luoyang, Wuhan, Shanghai
2026-02-19
Not yet open
Short-course Radiotherapy Combined With Serplulimab and Chemotherapy as Neoadjuvant Treatment for Resectable ESCC
NCT07403435Esophageal Squamous Cell Carcinoma (ESCC)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2
22
Wuhan
2026-02-15
Not yet open
A Clinical Study Evaluating the Safety and Efficacy of BCMA-GPRC5D CAR-T in Patients With Relapsed/Refractory Multiple Myeloma Who Have Received Three or More Lines of Treatment
NCT07376720Multiple Myeloma
Donghua Zhang
Not applicable
28
Wuhan
2026-02-15
Recruiting
Real-world Study of Scemblix in the Treatment of Chronic Myeloid Leukemia in China
NCT07375355Chronic Myeloid Leukemia in Chronic Phase
Novartis Pharmaceuticals
Observational
200
Wuhan
2026-02-12
Recruiting
Correlating EEG Dynamics With Consciousness Alteration Under Anesthesia
NCT07410702Altered State of Consciousness, General Anesthetics
Huazhong University of Science and Technology
Observational
250
Wuhan
2026-02-10
Recruiting
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
NCT07227415Carcinoma, Renal Cell, Advanced Renal Cell Carcinoma, Renal Cancer, Renal Neoplasm
Pfizer
Phase 1/2
224
Beijing, Chongqing, Wuhan, Changsha, Nanjing, Jinan, Ningbo
2026-02-10
By invitation
Safety and Efficacy of B/F/TAF in Pregnancy
NCT07666386HIV
Shi Zou
Observational
50
Wuhan
2026-02-09
Active, closed
Study of TRDC002 in the Diagnosis of Patients With PSMA-positive Prostate Cancer
NCT07236112Prostate Cancer
C Ray Therapeutics
Phase 1
6
Wuhan, Jinan
2026-02-08
Not yet open
The Influence of Explainability and Integrability of AI-CDSS on Usage Behavior Among Primary Care Physicians
NCT07401979Respiratory Tract Infections (RTI)
Huazhong University of Science and Technology
Not applicable
3,000
Wuhan
2026-02-05
Recruiting
Multimodal AI for Predicting Response to Neoadjuvant Immunotherapy in Gastric Cancer (PRISM-GC)
NCT07401199Gastric Cancer (GC), Locally Advanced Gastric Cancer
Qun Zhao
Observational
2,000
Fuyang, Cangzhou, Hengshui, Xingtai, Wuhan, Yichang, Baoding, Shijiazhuang
2026-02-05
Recruiting
A Study of LY4298445 in Healthy Participants and Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
NCT07276958Healthy, Systemic Lupus Erythematosus, Rheumatoid Arthritis
Eli Lilly and Company
Phase 1
68
Beijing, Changsha, Hefei, Shanghai, Wenzhou, Wuhan
2026-02-04
Recruiting
UCAR-T Targeting CD19/BCMA in Subjects With Autoantibody-Mediated Autoimmune Benign Hematological Diseases
NCT07441525Autoimmune Hemolytic Anemia, Primary Immune Thrombocytopenic Purpura, Evans Syndrome
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase EARLY_PHASE1
27
Wuhan
2026-02-03
Recruiting
A Study of BL-M07D1 in Combination With Pembrolizumab in Patients With Unresectable Locally Advanced or Metastatic HER2-Overexpressing Non-Squamous NSCLC
NCT07264816Non-squamous Non-small Cell Lung Cancer
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2
80
Wuhan
2026-02-03
Recruiting
A Study of GR1803 in Systemic Lupus Erythematosus
NCT07348055Systemic Lupus Erthematosus, Auto Immune Disease
Genrix (Shanghai) Biopharmaceutical Co., Ltd.
Phase 1/2
44
Wuhan
2026-02-02
Not yet open
Correlation Between EIT-based Pulse Wave Method for Pulmonary Perfusion Monitoring and Pulmonary Artery Catheter-based Stroke Volume Measurement
NCT07385963Shock, Acute Respiratory Distress Syndrome
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Observational
19
Wuhan
2026-02-02
Not yet open
A Phase II Study of Utidelone With Toripalimab in Advanced Cervical Cancer
NCT07363330Cervical Cancer, Recurrent, Metastatic
Zhongnan Hospital
Phase 2
32
Wuhan
2026-02-01
Recruiting
The Value of Bowel Sounds in Evaluating Postoperative Intestinal Function Recovery in Colorectal Cancer Patients
NCT07705139Bowel Sounds, Colorectal Cancer, Intestinal Obstruction, Postoperative Ileus
Zhongnan Hospital
Observational
172
Wuhan
2026-02-01
Recruiting
Efficacy of Acupuncture-Mesalazine Combination Therapy in Ulcerative Colitis.
NCT07389824Ulcerative Colitis
Qin Yu
Not applicable
66
Wuhan
2026-02-01
Not yet open
Efficacy and Safety of Xeligekimab in the Treatment of Non-Radiographic Axial Spondyloarthritis
NCT07339566Nr-axial Spondyloarthritis, Non-Radiographical Axial Spondyloarthritis
Lingli Dong
Phase 2/3
40
Wuhan
2026-01-31
Not yet open
Preliminary Evaluation of Clinical Application of SPECT Imaging Targeting GPC3
NCT07353333HCC, SPECT-CT
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Not applicable
6
Wuhan
2026-01-30
Not yet open
Head to Head, Prospective, Open Label Multicenter Study on the Diagnostic Efficacy of GPC3 Targeted PET Imaging and Enhanced Magnetic Resonance Imaging for Hepatocellular Carcinoma
NCT07352345Malignant Neoplasm of Liver
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase EARLY_PHASE1
150
Wuhan
2026-01-30
Recruiting
Adebrelimab Combined With Gemcitabine, Cisplatin, and Simvastatin for Advanced Biliary Tract Cancer
NCT07392541Advanced Biliary Tract Carcinoma
Tongji Hospital
Phase 1/2
29
Wuhan
2026-01-30
Not yet open
Safety and Efficacy of CLL1 CAR-T Followed by Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia
NCT07342244AML, AML (Acute Myeloid Leukemia)
Donghua Zhang
Not applicable
18
Wuhan
2026-01-30
Recruiting
Prospective Validation of an AI Model for Predicting Liver Metastasis in Colorectal Cancer
NCT07392567Colorectal Cancer Liver Metastasis
Tongji Hospital
Observational
160
Wuhan
2026-01-30
Recruiting
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
NCT07227298Advanced/Metastatic Non-Small Cell Lung Cancer, Carcinoma, Non-Small Cell Lung, Non-Small Cell Lung Cancer
Pfizer
Phase 1/2
162
Beijing, Wuhan, Nanjing, Shanghai, Taizhou
2026-01-30
Recruiting
CAR-T Therapy Targeting CD19 and BCMA in Highly Sensitized Kidney Transplant Participants
NCT07350837Highly Sensitized Patients Awaiting Kidney Transplant
Tongji Hospital
Phase EARLY_PHASE1
12
Wuhan
2026-01-28
Recruiting
A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
NCT07244263Hidradenitis Suppurativa
Takeda
Phase 2
90
Beijing, Guangzhou, Wuhan, Shanghai, Hangzhou
2026-01-26
Recruiting
Postoperative Radiotherapy for Early-stage Oral Tongue Squamous Cell Carcinoma Patients With Risk Factors: a Prospective, Multicenter, Randomized Controlled, Open-labelled Trial
NCT07402525Oral Tongue Squamous Cell Carcinoma
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
190
Bengbu, Chaoyang, Fuzhou, Guandong, Harbin, Wuhan, Changsha, Nanchang
2026-01-26
Recruiting
Impact of Pre-Hospital Heparin Loading in STEMI Patients for Primary PCI: The HELP-PCI-2 Trial
NCT07361783Primary PCI, ST-elevation Myocardial Infarction (STEMI)
Chen Jing
Not applicable
6,294
Wuhan
2026-01-25
Recruiting
Evaluate the Use of [18F]-APN-1607 PET in Subjects With AD-related Cognitive Impairment and Subjects With Normal Cognitive Function
NCT07422857Subjects With Mild Cognitive Impairment (MCI) of AD, Alzheimer's Disease (AD) Dementia
JYAMS PET Research & Development Limited
Phase 3
316
Wuhan, Shanghai
2026-01-22
Not yet open
Phase Ib/II Study of QL1706 + Fruquintinib + SCRT vs. Standard Third-Line Therapy in Unresectable Liver-Metastatic pMMR/MSS Colorectal Cancer: Safety, Tolerability, and Efficacy.
NCT07353268Colorectal Cancer
Tao Zhang
Phase 2
76
Wuhan
2026-01-21
Not yet open
Brain Stimulation for Postherpetic Neuralgia: A Randomized Sham-Controlled Trial
NCT07352553Postherpetic Neuralgia
Huazhong University of Science and Technology
Not applicable
94
Wuhan
2026-01-20
Recruiting
A Study on the Effect of Medical Students' Literature Reading Patterns on Cognitive Load and Academic Writing Ability
NCT07460258Accuracy in Understanding the Core Content of English Medical Literature
Zhongnan Hospital
Observational
160
Wuhan
2026-01-20
By invitation
A Study on the Efficacy and Safety of Endoscopic Ultrasound-guided Gastro-/Duodeno-cholecystostomy for the Treatment of Gallstones.
NCT07522385Gall Stones, Gall Stones (& [Calculus - Gall Bladder])
Tongji Hospital
Not applicable
60
Wuhan
2026-01-20
Recruiting
A Study (Phase 1b/2) of GS3-007a Oral Treatment in Children With Growth Hormone Deficiency (PGHD)
NCT07264595Pediatric Growth Hormone Deficiency
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1/2
88
Wuhan
2026-01-18
Recruiting
A Clinical Study Exploring the Safety, Efficacy and Cell Metabolic Dynamics of Universal CD19 / 20 Car-t Cell Injection in Moderate to Severe Refractory Systemic Lupus Erythematosus
NCT07339332Systemic Lupus Erythematosus (SLE)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase EARLY_PHASE1
12
Wuhan
2026-01-16
Recruiting
Safety, Efficacy and Cellular Metabolic Dynamics of CT1195E in Patients With Refractory / Progressive SSC
NCT07355972SSc-Systemic Sclerosis
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase EARLY_PHASE1
12
Wuhan
2026-01-16
Recruiting
CD19 CAR-T Therapy for Refractory Pemphigus Vulgaris
NCT07681388Pemphigus Vulgaris
Jinbo Chen
Not applicable
3
Wuhan
2026-01-15
Not yet open
Evaluation of the Diagnostic Efficacy of a ฮฑvฮฒ6/FAP-Targeting Heterodimeric Probe in Patients With Malignant Solid Tumors
NCT07385950PET / CT, Solid Tumors, Adult
Zhongnan Hospital
Observational
100
Wuhan
2026-01-15
Recruiting
A Clinical Trial Testing the Safety of the Investigational Drug Pumitamig (BNT327) and How Well it Works in Patients With Recurrent Glioblastoma
NCT07297212Recurrent Glioblastoma
BioNTech SE
Phase 2
75
Beijing, Chongqing, Jinan, Shanghai, Shenzhen, Wuhan
2026-01-15
Recruiting
A Phase I Trial of A-CAR032 in Participants With mCRPC
NCT07344311Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer
Shanghai AbelZeta Ltd.
Phase 1
27
Beijing, Wuhan, Xuzhou, Hangzhou
2026-01-13
Not yet open
A Clinical Study to Evaluate LVIVO-TaVec400 for the Treatment of Relapsed/Refractory Multiple Myeloma๏ผˆLB2505-0001๏ผ‰
NCT07399444Multiple Myeloma (MM)
Institute of Hematology & Blood Diseases Hospital, China
Phase EARLY_PHASE1
38
Zhengzhou, Wuhan, Xuzhou, Nanchang, Beijing, Tianjin
2026-01-10
Recruiting
Clinical Study of (A-319) in the Treatment of Active Rheumatoid Arthritis
NCT07347860Rheumatoid Arthritis (RA)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase EARLY_PHASE1
12
Wuhan
2026-01-08
Recruiting
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
NCT07253285Overweight, Obesity
Novo Nordisk A/S
Phase 3
460
Beijing, Zhengzhou, Wuhan, Changchun, Jinan, Shanghai, Chengdu
2026-01-08
Not yet open
Phase โ…ก Clinical Trial of Influenza Virus Split Vaccine for Individuals Aged 60 Years and Above
NCT07327398Influenza
Shanghai Institute Of Biological Products
Phase 2
1,200
Wuhan
2026-01-07
Recruiting
Exploratory Study of Orelabrutinib in the Treatment of Early-stage Untreated MZL
NCT07441993Marginal Zone Lymphoma
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
30
Guangzhou, Zhengzhou, Wuhan, Xiangyang, Changsha, Nanjing, Nantong, Nanchang
2026-01-05
Not yet open
ICSI Versus Conventional IVF in Couples With Unexplained Infertility
NCT07294027Unexplained Infertility
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
848
Beijing, Huangshi, Wuhan, Xiangyang, Hangzhou, Jiaxing, Ningbo
2026-01-01
Not yet open
A Prospective, Multicenter, Open-label, Randomized Clinical Trial to Evaluate the Efficacy, Durability, and Safety of Aflibercept 8mg in Different Treatment Regimens in Chinese Patients With Polypoidal Choroidal Vasculopathy (PCV)
NCT07365371Polypoidal Choroidal Vasculopathy (PCV), Neovascular Age Related Macular Degeneration (AMD)
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 4
174
Beijing, Foshan, Harbin, Zhengzhou, Wuhan, Nanjing, Nanchang, Jilin City
2026-01-01
Recruiting
A Pilot Study Evaluating ฮฒ-hydroxybutyrate Supplementation Concomitant to Short-Course Radiotherapy Followed by Immunotherapy Combined With CAPEOX Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer
NCT07239466Rectal Cancer, Radiotherapy, Immunotherapy, Chemotherapy
Tao Zhang
Phase 2
25
Wuhan
2026-01-01
Not yet open
Critical Illness After Hematopoietic Cell Transplantation
NCT07328724Critical Illness, Ventilated Patients, Hematopoetic Stem Cell Transplantation, Transplant Complication
Peking University People's Hospital
Observational
4,000
Beijing, Chongqing, Hangzhou, Harbin, Tianjin, Wuhan
2026-01-01
Recruiting
Construction of AI Model for Precision Imaging Diagnosis of Cranial Diseases
NCT07446842Cranial Diseases (e.g., Brain Tumors, Stroke, Neurodegenerative Disorders)
Tongji Hospital
Observational
1,000
Wuhan
2026-01-01
Recruiting
Cardiovascular Outcomes and Risk Evaluation Among Recipients of Hematopoietic Stem Cell Transplantation
NCT07349498Hematopoietic Stem Cell Transplantation, Transplant Complication, Cardiovascular Events
Peking University People's Hospital
Observational
10,000
Beijing, Chongqing, Guangzhou, Shenzhen, Harbin, Zhengzhou, Wuhan, Xi'an
2026-01-01
Not yet open
ACE1831 in Adult Subjects With Relapsed/Refractory Systemic Lupus Erythematosus ๏ผˆSLE๏ผ‰
NCT07314567System Lupus Erythematosus(SLE)
Tongji Hospital
Not applicable
22
Wuhan
2026-01-01
Recruiting
Clinical Study Evaluating the Safety and Efficacy of BAFFR CAR-T Therapy for Relapsed/Refractory B-cell Malignancies
NCT07345728Relapsed/Refractory B-cell Malignancies
Donghua Zhang
Not applicable
28
Wuhan
2026-01-01
Not yet open
Fospropofol Disodium ED95 for Elderly Spinal Anesthesia Sedation
NCT07333508Lower Extremity Surgery
Ya-Qun Zhou
Phase 4
60
Wuhan
2026-01-01
Not yet open
Multicenter RCT: LED Red Light Dose-Response in Myopia Progression Control
NCT07330180Myopia, Myopia, Progressive
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
364
Chongqing, Foshan, Zhengzhou, Wuhan, Shenyang, Guilin, Xiโ€™an
2026-01-01
Recruiting
A Study of Chiglitazar in Patients With Metabolic Dysfunction-associated Steatohepatitis and Type 2 Diabetes Mellitus
NCT07303803MASH - Metabolic Dysfunction-Associated Steatohepatitis, T2DM (Type 2 Diabetes Mellitus)
Shanghai Jiao Tong University School of Medicine
Phase 2
300
Beijing, Chongqing, Fuzhou, Guangzhou, Wuhan, Shiyan, Changsha, Changchun
2026-01-01
Recruiting
Prospective Clinical Database Construction for Liver Cancer Diagnosis and Treatment
NCT07587216Liver Cancer (Primary and Metastatic)
Tongji Hospital
Observational
800
Wuhan
2026-01-01
Not yet open
Efficacy Evaluation of Glimepiride in Patients With Type 2 Diabetes Mellitus and Chronic Heart Failure With Reduced Ejection Fraction.
NCT07288749Type 2 Diabetes Mellitus (T2DM), Chronic Heart Failure (CHF)
Tongji Hospital
Phase 3
1,484
Wuhan
2026-01-01
Active, closed
Desvenlafaxine for Preventive Treatment of Frequent Migraines
NCT07385755Migraine
Tongji Hospital
Not applicable
440
Wuhan
2026-01-01
Not yet open
KN5501 Cell Injection for Refractory SLE(CLEAR)
NCT07358988Systemic Lupus Erthematosus (SLE)
Ruitherapeutics Co., LTD
Phase 1
36
Bengbu, Beijing, Luoyang, Wuhan, Nanjing, Shanghai
2026-01
Not yet open
Efficacy and Safety of TT-00420 (Tinengotinib) Tablets Versus Chemotherapy in Patients With Advanced Intrahepatic Cholangiocarcinoma Harboring FGFR2 Fusions/Rearrangements or Mutations
NCT07328919Intrahepatic Cholangiocarcinoma (Icc), Advanced Cholangiocarcinoma
TransThera Sciences (Nanjing), Inc.
Phase 3
138
Hefei, Fuzhou, Guangzhou, Zhengzhou, Wuhan, Changsha, Nanjing, Nanchang
2026-01
Not yet open
Predictive Value of Minimal Residual Disease for Postoperative Recurrence and Adjuvant PD-1 Inhibitor in HCC
NCT07350824HCC, Minimal Residual Disease, Recurrence
Tongji Hospital
Not applicable
276
Wuhan
2025-12-31
Not yet open
Clinical Study on the Safety and Efficacy of CD20/CD19 Cell Injection in the Treatment of Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
NCT07345741R/R B-NHL, Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (R/R B-NHL)
Donghua Zhang
Not applicable
28
Wuhan
2025-12-31
Not yet open
TACE Combined With Tislelizumab, Lenvatinib, and Carvedilol for Unresectable HCC With Cirrhotic Portal Hypertension
NCT07350070HCC, Liver Cirrhosis, Portal Hypertension
Tongji Hospital
Phase 2
78
Fuzhou, Nanning, Taihe, Wuhan, Jinan, Qingdao
2025-12-31
Recruiting
Intra-arterial Recombinant Human Tenecteplase Tissue-type Plasminogen Activator (rhTNK-tPA) Thrombolysis for Acute Medium Vessel Occlusion
NCT07302854Acute Ischemic Stroke, Medium Vessel Occlusion
Xiang Luo
Phase 2/3
382
Wuhan
2025-12-30
Not yet open
Evaluation of the Efficacy and Safety of an Intensified Strategy of Intratonsillar Immunotherapy (ITIT) for Allergic Rhinitis: A Multicenter, Randomized, Double-blind, Controlled Trial
NCT07269509Allergic Rhinitis
Renmin Hospital of Wuhan University
Not applicable
276
Wuhan
2025-12-30
Recruiting
Apatinib Mesylate and Camrelizumab Combined With TACE as Neoadjuvant Therapy for Hepatocellular Carcinoma
NCT07154082Hepatocellular Carcinoma (HCC)
Wei Zhang
Phase 2
27
Wuhan
2025-12-30
Recruiting
A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
NCT07225569Hidradenitis Suppurativa
Sanofi
Phase 2
144
Beijing, Changsha, Shanghai, Wuhan
2025-12-29
Recruiting
A Prospective Observational Study of First-Line Systemic Therapy Combined With Celiac Plexus Blockade for Advanced Biliopancreatic Cancer With Pain
NCT07326137Advanced Biliary Tract Cancer(BTC), Advanced Pancreatic Cancers, Cancer-related Pain
Tongji Hospital
Observational
103
Wuhan
2025-12-26
Not yet open
Prediction of Targeted Therapy Efficacy in EGFR-mutant Lung Cancer Patients Using AI-based Multimodal Data
NCT07287904Lung Cancer (NSCLC), EGFR Activating Mutation, Adenocarcinoma Lung, Postoperative Adjuvant Therapy
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Observational
1,000
Wuhan
2025-12-25
Recruiting
A Multicenter, Prospective Clinical Trial With a Concurrent Control Evaluating Methotrexate Combined With Rituximab,Sintilimab and Pirtobrutinib vs. Investigator-Selected Standard of Care in Treatment-Naive PCNSL
NCT07350850PCNSL, Primary Central Nervous System Lymphoma
Tongji Hospital
Phase 2
77
Xiamen, Wuhan, Changchun, Taiyuan
2025-12-25
Recruiting
Gut Microbiota and Diarrhea in Breast Cancer Patients Receiving Pyrotinib
NCT07264985Breast Cancer, Drug-Related Side Effects, Diarrhea
Hubei Cancer Hospital
Observational
60
Wuhan
2025-12-25
Recruiting
A Trial of SHR-7787 Injection Combined With Other Anti-tumor Drugs in Patients With Malignant Solid Tumors
NCT07268040Malignant Solid Tumors
Shanghai Hengrui Pharmaceutical Co., Ltd.
Phase 2
400
Wuhan, Shanghai
2025-12-23
Recruiting
A Study on Combined Low-pass Whole-genome and Methylome Testing of Bloody Nipple Discharge Specimens for Benign-Malignant Differentiation.
NCT07250204Breast Cancer, Nipple Discharge
Hubei Cancer Hospital
Observational
60
Wuhan
2025-12-21
Recruiting
Observational Study of Gut Microbiota in Abemaciclib-Treated Patients With and Without Diarrhea
NCT07264998Breast Neoplasms, Hormone Receptor-Positive Breast Cancer, Abemaciclib, Abemaciclib-related Diarrhea
Hubei Cancer Hospital
Observational
60
Wuhan
2025-12-21
By invitation
To Explore the Value of Magnetic Resonance Imaging in Noninvasive Quantitative Evaluation of Graft Function After Simultaneous Pancreas-kidney Transplantation
NCT07001917Simultaneous Pancreas-Kidney Transplantation
Zhen Li
Observational
500
Wuhan
2025-12-20
Rows per page Showing 201–300 of 1343
Previous 1 2 3 4 5 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/wuhan?page=3

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1,343 of those studies with a site in Wuhan.

How many clinical trials are recruiting in Wuhan?

798 of the 1,343 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 226 have not yet opened recruitment, 281 are active but closed to new participants, and 38 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.